Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their here robustness in expressing complex molecules. Optimizing these processes involves adjusting various parameters, including cell line engineering, media formulation, and bioreactor conditions. A key goal is to amplify antibody production while minimizing product